| 标题 |
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Kidney International 作者:Hong Zhang; Dana V. Rizk; Vlado Perkovic; Bart Maes; Naoki Kashihara; et al 出版日期:2023-10-31 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)